Early-Onset Neonatal Sepsis Clinical Trial
Official title:
PROcalcitonin and Presepsin-guided Decision for Antibiotic Prophylaxis of Early-Onset SEpsis in Preterm Infants: a Multicentre, Randomised Controlled Trial
The goal of this randomized controlled study is to compare the outcome of preterm infants who will receive the standard antibiotic prophylaxis for EOS or Procalcitonin/Presepsin-guided antibiotic prophylaxis of early onset sepsis (EOS). The main question it aims to answer is: • Does Procalcitonin/Presepsin-guided antibiotic prophylaxis of (EOS) increase survival without major morbidities, including IVH >3 grade, PVL, ROP >3 grade in either eye, NEC >2 grade, BPD, or LOS. Infants with gestational age between 25+0 and 31+6 weeks of gestation or a birth weight <1500 g will be eligible for enrollment in the study. Participants will be randomized to receive standard antibiotic prophylaxis for EOS (standard group) or to receive antibiotic prophylaxis for EOS on the basis of PCT/P-SEP measured within 3 h of life (intervention group).
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06076200 -
Population Pharmacokinetic of Piperacillin/Tazobactam in Maternal and Neonatal Populations
|
||
| Completed |
NCT03694613 -
Utility of Placental/Umbilical Cord Blood in Early Onset Neonatal Sepsis in Very Low Birth Weight Infants
|
N/A | |
| Recruiting |
NCT03819192 -
Predicting EONS in PPROM Patients
|
||
| Recruiting |
NCT03997266 -
NICU Antibiotics and Outcomes Trial
|
Phase 4 | |
| Recruiting |
NCT05329701 -
Individualized Duration of Antibiotic Treatment in Early Onset Infection in Newborns.
|
Phase 4 | |
| Not yet recruiting |
NCT06377397 -
Selective Antibiotics When Symptoms Develop Versus Universal Antibiotics for Preterm Neonates
|
Phase 3 | |
| Recruiting |
NCT06197269 -
Efficacy And Safety Of Short Course Antibiotic Therapy In Preterm Neonates With Early Onset Sepsis
|
N/A | |
| Not yet recruiting |
NCT06100614 -
Presepsin to Safely Reduce Antibiotics in Preterm Infants
|
N/A |